Loading
Loading…
Loading…
| # | Company | Rank | Status |
|---|---|---|---|
| 1 | 0Accepted-Finance | 0 | Accepted-Finance Detailed report is placed at attachment and will also be published on CNCI website under Tender tab. |
| 2 | 0Accepted-Finance | 0 | Accepted-Finance Detailed report is placed at attachment and will also be published on CNCI website under Tender tab. |
| 3 | 0Accepted-Finance 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | 0 | Accepted-Finance Detailed report is placed at attachment and will also be published on CNCI website under Tender tab. |
| 4 | 0Accepted-Finance | 0 | Accepted-Finance Detailed report is placed at attachment and will also be published on CNCI website under Tender tab. |
| 5 | 0Accepted-Finance B 175 EAST OF KAILASH NEW DELHI DELHI 110065 | SOUTH EAST DELHI | DELHI | 110065 | 0 | Accepted-Finance Detailed report is placed at attachment and will also be published on CNCI website under Tender tab. |
Tender Value
Refer Docs
EMD Value
₹2 L
Closing Date
14 Dec 2023, 2:00 pmClosed
DIRECTOR, CHITTARANJAN NATIONAL CANCER INSTITUTE
2nd Campus - Street No.299, Plot No. DJ 01, Premises No. 02-0321, Action Area ID, New Town, Kol-700160
supply of Medicinal Items (Anti- Cancer Drugs) on two years rate contract basis for CNCI both the campuses
2023_CNCI_779339_1
CNCI/e NIT-56-1/2023-24
Open Tender
Drugs and Pharmaceutical Products
Item Rate
45 days
CHITTARANJAN NATIONAL CANCER INSTITUTE
Please refer Tender documents.
3 documents required · 3 mandatory
₹0
₹2 L
Yes
10 Apr 2024
3 Nov 2023
15 Dec 2023
4 Nov 2023
14 Dec 2023
4 Nov 2023
Inj. Docetaxel 80mg -RTU
Inj. Oxaliplatin 50
Tab. Alpelisib 200 Mg
Tab. Alpelisib 250 Mg
Tab. Capmatinib 150 Mg
Tab. Capmatinib 200 Mg
Tab. Dabrafenib 50 mg
Tab. Dabrafenib 75mg
Tab. Trametinib 0.5 Mg
Inj. Paclitaxel Nanoparticle 100 mg
Inj. Paclitaxel Nanoparticle 300 mg
Gefitinib Dispersible Tablet 250 mg
Abiraterone Acetate Dispersible Tablet 250 mg
Abiraterone Acetate Dispersible Tablet 500 mg
Inj. Inotuzumab 1 mg
Inj. Durvalumab 500 mg
Inj. luspatercept 25 mg
Inj. luspatercept 75 mg
Tab. Darolutamide 300 mg
Inj. Triptorelin tamoate 3.75 mg
Inj. Triptorelin tamoate 11.25 mg
Inj. Triptorelin tamoate 22.5 mg
Inj. Panitumumab 100 mg
MEDICINE 5
MEDICINE 6
MEDICINE 7
Venus Remedies Ltd.
M/s Beta Drugs Limited
sandoz pvt ltd
novartis health care pvt ltd
Fresenius kabi Oncology Ltd
Sun Pharma Laboratories Limited
Dr Reddys Laboratories Limited
Bristol Myers Squibb India Private Limited
ASTRAZENECA PHARMA INDIA LIMITED
Pfizer Products India Pvt. Ltd
M/s ALBINO LIFESCIENCES PVT. LTD.
Bristol Myers Squibb India Private Limited
Fresenius kabi Oncology Ltd
novartis health care pvt ltd
Pfizer Products India Pvt. Ltd
ASTRAZENECA PHARMA INDIA LIMITED
sandoz pvt ltd
Dr Reddys Laboratories Limited
stage.html
html • 0.07 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .